| Name | Title | Contact Details |
|---|
Mental Health Corporation of Denver is a Denver, CO-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
SANUWAVE, Inc. is an emerging leader in the development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures. SANUWAVE`s portfolio of products and product candidates activate biologic signaling and angiogenic reponses, including revascularization and microcirculation, helping to restore the body`s normal healing processes and regeneration. These devices, based on Pulsed Acoustic Cellular Expression (PACE™) technology, are being developed and commercialized for use in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions.
Build a portfolio of market-leading medical device companies comprised of FDA approved, high revenue-generating technologies and products from the largest market opportunity segments and emerging research and development technologies. Build a portfolio of market-leading medical device companies comprised of FDA approved, high revenue-generating technologies and products from the largest market opportunity segments and emerging research and development technologies.
Photo-Stat, LP is a Irving, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Founded in 2011, Sight Sciences develops and commercializes intelligently designed and engineered products that target the underlying causes of the world`s most prevalent eye diseases. The company`s surgical glaucoma product portfolio features the OMNI Surgical System, a dually indicated MIGS device that facilitates the performance of both ab interno trabeculotomy and transluminal viscoelastic delivery. Using proprietary multi-modal functionality, OMNI allows surgeons to target all three sources of resistance in the conventional outflow pathway (trabecular meshwork, Schlemm`s canal and collector channels) with a single device and single corneal incision. The company`s non-surgical dry eye product portfolio consists of the TearCare for ophthalmologists and optometrists. TearCare is a software-controlled, wearable, therapeutic eyelid technology designed to melt and clear obstructions of the meibomian glands within the eyelids. Leveraging the full functionality of the blinking eye, proprietary SmartLid™ technology is designed to conform to all eyelid anatomies and achieve therapeutic meibum melting temperatures at the tarsal conjunctiva thereby clearing meibomian gland obstructions while sparing the cornea. Improved meibum production results in a higher quality lipid layer and higher quality tears.